3-Fluoro-4-(hydroxymethyl)benzonitrile, 95.0%, 25g

methyl 5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 250mg

Ethyl 2-Bromo-2-(3-chlorophenyl)acetate, 95.0%, 100mg

2-(2-OXO-2-(4-METHOXYPHENYL)ETHYL)MALONONITRILE, 95.0%, 250mg

(1-Phenyl-1H -tetrazol-5-ylsulfanyl)-acetic acid, 95+%, 1g

2-Propanol, min. 99.5%, for synthesis, 5 l, plastic packaging.

1-(3-Chloropropyl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione, 95.0%, 100g

5,5-Dimethyl-3-(benzylamino)cyclohex-2-en-1-one, 95.0%, 2g

5-iso-Propyl-5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzodiazepine-4-carboxylic acid, 95.0%, 1g

2-(3-Chlorophenyl)acetamide, 95.0%, 25g

2-Bromo-5-propylthiophene, 95.0%, 100mg

2-[2-(4-ethoxyphenyl)-1H-1,3-benzodiazol-6-yl]-6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazole trihydrochloride, 98%, 100mg

(1S,2R)-2-Aminocyclohexanol hydrochloride, 95.0%, 25g